Menu
Recruiting NCT07207564

Integrating Molecular Pathology, Radiology, and Genetics to Improve Breast Cancer Risk

— Observational Breast Carcinoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Non-Interventional Study.
Who it may be relevant to
Registry conditions: Breast Carcinoma. Basic parameters: 18 years — 100 years · Female.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Unsure about the terms? Read our patient guide →

Overview

The purpose of this research is to better understand how benign breast diseases might lead to breast cancer, focusing on genetic factors and including a diverse range of participants to improve future diagnosis and treatment.

Interventions

  • Other Non-Interventional Study
    Non-interventional study

Primary outcome measures

  • Pathologic features [Time frame: Baseline (collection of blood or saliva sample)]
  • Radiologic features [Time frame: Baseline (collection of blood or saliva sample)]
  • Molecular features [Time frame: Baseline (collection of blood or saliva sample)]

Eligibility criteria

Inclusion criteria

  • Female patients, ages 18 to 100 years
  • Had a benign breast biopsy at Mayo Clinic between 2002-2022

Exclusion criteria

  • All male patients
  • Prior or concomitant diagnosis of BC
  • Diagnosis of BC within six months of benign breast disease
  • Denial of research authorization
  • Concurrent or post-biopsy bilateral prophylactic mastectomy

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Observational model
Cohort

Study locations

United States · 2 centers
  • Mayo Clinic in Florida — Jacksonville
  • Mayo Clinic in Rochester — Rochester

Identifiers

NCT: NCT07207564 · 23-009436 · NCI-2025-06873 · 23-009436

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗